Werbung
Werbung
RCUS
Arcus Biosciences, Inc.
21.42
USDGesponsert
-1.78
-7.69%
08. Jan., 11:49 UTC -5
Offen
RCUS Ergebnisberichte
Positives Überraschungsverhältnis
RCUS übertreffen die 17 der letzten 31Schätzungen.
55%
Nächster Bericht
Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$36.88M
/-$1.06
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+41.84%
/-16.54%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+41.84%
/+2.91%
Arcus Biosciences, Inc. earnings per share and revenue
On 28. Okt. 2025, RCUS reported earnings of -1.27 USD per share (EPS) for Q3 25, beating the estimate of -1.33 USD, resulting in a 4.95% surprise. Revenue reached 26.00 million, compared to an expected 21.83 million, with a 19.11% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -1.06 USD, with revenue projected to reach 36.88 million USD, implying an decrease of -16.54% EPS, and increase of 41.84% in Revenue from the last quarter.
FAQ
What were Arcus Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arcus Biosciences, Inc. reported EPS of -$1.27, beating estimates by 4.95%, and revenue of $26.00M, 19.11% above expectations.
How did the market react to Arcus Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved up 2.06%, changed from $19.88 before the earnings release to $20.29 the day after.
When is Arcus Biosciences, Inc. expected to report next?
The next earning report is scheduled for 23. Feb. 2026.
What are the forecasts for Arcus Biosciences, Inc.'s next earnings report?
Based on 12
analysts, Arcus Biosciences, Inc. is expected to report EPS of -$1.06 and revenue of $36.88M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung